Emcure Pharmaceuticals Limited
Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.
A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.
US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.